CHI-KAT8i5 suppresses ESCC tumor growth by inhibiting KAT8-mediated c-Myc stability
Dandan Zhang(Qingdao University), Zigang Dong(China-US (Henan) Hormel Cancer Institute), Qiong Wu(Zhengzhou University), Dengyun Zhao(Zhengzhou University), Wenna Nie(China-US (Henan) Hormel Cancer Institute), Xiang Pu(Zhengzhou University), Xinyu He(Chinese Academy of Medical Sciences & Peking Union Medical College), Kyle Vaughn Laster(China-US (Henan) Hormel Cancer Institute), Pan Li(Brigham and Women's Hospital), Yunfeng Gao(China-US (Henan) Hormel Cancer Institute), Huifang Wei(Ningbo University of Technology), Ming Jiang(China-US (Henan) Hormel Cancer Institute), Yafei Zhi(Zhengzhou University), Kangdong Liu(Zhengzhou University)
Cited by 1
Related Papers
Genetic Control of Individual Differences in Gene-Specific Methylation in Human Brain
|The American Journal of Human Genetics|2010|394
Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
|Proceedings of the National Academy of Sciences|1994|388
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2019|387
Association analyses identify six new psoriasis susceptibility loci in the Chinese population
|Nature Genetics|2010|317
Singleton deletions throughout the genome increase risk of bipolar disorder
|Molecular Psychiatry|2008|148